http://www3.weforum.org/docs/WEF_GlobalRisks_Report_2010.pdfIn the United States, men with chronic disease worked 6.1% fewer hours and women worked 3.9% fewer hoursA recent study conducted by the American Cancer Society estimated the cost of DALYs due to cancer worldwide in 2008 at US$ 895 billionFor the developing world, a US Institute of Medicine (IOM) report on the macroeconomic impacts of cardiovascular disease and chronic diseases in a number of countries (Fuster & Kelly, 2010) suggests that the economic impact of CVD and related chronic diseases (such as diabetes and COPD) is large. Estimates ranged from an annual US$ 3 billion for direct medical costs of obesity-related diabetes, coronary heart disease, hypertension and stroke in China to US$ 72 billion for treatment of and productivity losses due to five chronic conditions in Brazil.
MHEALTH PANEL―Lost output from five conditions (cancer,cardiovascular disease, chronic respiratorydiseases, diabetes and mental health) overthe period 2011-2030 is estimated at nearlyUS$ 47 trillion‖ Source: World Economic Forum: the global economic burden of NCD’s McCann Worldgroup 1
MHEALTH PANEL - GLOBAL ECONOMIC RISK LANDSCAPEWORLD ECONOMIC FORUM REPORT 2010 McCann Worldgroup 2
MHEALTH PANEL - THE ECONOMIC IMPACT OF NCD’S―In China, reducing cardiovascular mortality by 1 percentper year over a 30-year period (2010–2040) could generate aneconomic value equivalent to 68 percent of the country’s realGDP in 2010—more than US$10.7 trillion at purchasing powerparity‖―A recent study illustrated the economic impact of NCDs inIndia by estimating that if NCDs were ―eliminated‖, thecountry’s 2004 GDP would have been 4 to 10 percentgreater.‖ Source: World Economic Forum: the global economic burden of NCD’s McCann Worldgroup 3
MHEALTH PANEL - MAKING IT HAPPENMobile is the platform that can enable moreefficient healthcare provisioning on anindividual level but also a macro level.To make this happen we needto create an ecosystem where both mobileand healthcare stakeholders work together McCann Worldgroup 4